Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathalie Chaput

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
The European Respiratory Journal|December 2, 2015
Foxp3+ cells are running the show in patients with surgically resected nonsmall cell lung cancerNathalie Chaput, Aurelien Marabelle
Seminars in Immunopathology|December 22, 2010
Exosomes: immune properties and potential clinical implementationsNathalie Chaput, Clotilde Théry
Bulletin Du Cancer|June 17, 2006
[Innate defence against tumor cells: the killer cell IKDC]Nathalie Chaput, Julien Taieb, Laurence Zitvogel
Critical Reviews in Immunology|July 29, 2005
Dendritic cell-derived exosomes as cell-free peptide-based vaccinesJulien Taïeb, Nathalie Chaput, Laurence Zitvogel
Current Opinion in Oncology|January 13, 2016
Predictive biomarkers for programmed death-1/programmed death ligand immune checkpoint inhibitors in nonsmall cell lung cancerJordi Remon, Nathalie Chaput, David Planchard
Bulletin Du Cancer|January 23, 2015
[Breaking immune tolerance in cancer]Mélanie Desbois, Stéphane Champiat, Nathalie Chaput
Medecine Sciences : M/S|July 11, 2006
[A new dendritic cell implicated in antitumoral immunity]Nathalie Chaput, Julien Taieb, Evelyn Ullrich, et al.
Expert Opinion on Biological Therapy|June 15, 2005
The potential of exosomes in immunotherapyNathalie Chaput, Julien Taïeb, Fabrice André, et al.
Cancer Discovery|November 2, 2021
New Immunotherapy Combinations Enter the Battlefield of Malignant MesotheliomaMihaela Aldea, Jose Carlos Benitez, Nathalie Chaput, et al.
European Journal of Cancer (Oxford, England : 1990)|August 10, 2021
Cancer and immunotherapy: a role for microbiota compositionFiona Pham, Fabien Moinard-Butot, Clélia Coutzac, et al.
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
The European Respiratory Journal|December 2, 2015
Foxp3+ cells are running the show in patients with surgically resected nonsmall cell lung cancerNathalie Chaput, Aurelien Marabelle
Seminars in Immunopathology|December 22, 2010
Exosomes: immune properties and potential clinical implementationsNathalie Chaput, Clotilde Théry
Bulletin Du Cancer|June 17, 2006
[Innate defence against tumor cells: the killer cell IKDC]Nathalie Chaput, Julien Taieb, Laurence Zitvogel
Critical Reviews in Immunology|July 29, 2005
Dendritic cell-derived exosomes as cell-free peptide-based vaccinesJulien Taïeb, Nathalie Chaput, Laurence Zitvogel
Current Opinion in Oncology|January 13, 2016
Predictive biomarkers for programmed death-1/programmed death ligand immune checkpoint inhibitors in nonsmall cell lung cancerJordi Remon, Nathalie Chaput, David Planchard
Bulletin Du Cancer|January 23, 2015
[Breaking immune tolerance in cancer]Mélanie Desbois, Stéphane Champiat, Nathalie Chaput
Medecine Sciences : M/S|July 11, 2006
[A new dendritic cell implicated in antitumoral immunity]Nathalie Chaput, Julien Taieb, Evelyn Ullrich, et al.
Expert Opinion on Biological Therapy|June 15, 2005
The potential of exosomes in immunotherapyNathalie Chaput, Julien Taïeb, Fabrice André, et al.
Cancer Discovery|November 2, 2021
New Immunotherapy Combinations Enter the Battlefield of Malignant MesotheliomaMihaela Aldea, Jose Carlos Benitez, Nathalie Chaput, et al.
European Journal of Cancer (Oxford, England : 1990)|August 10, 2021
Cancer and immunotherapy: a role for microbiota compositionFiona Pham, Fabien Moinard-Butot, Clélia Coutzac, et al.
Pageof 14